Bionano Genomics, Inc.
BNGO
$3.58
-$0.07-1.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -83.70M | -112.02M | -135.78M | -204.10M | -226.79M |
| Total Depreciation and Amortization | 13.65M | 14.23M | 15.42M | 13.42M | 13.73M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.37M | 24.47M | 32.28M | 89.73M | 98.31M |
| Change in Net Operating Assets | 1.12M | 4.40M | -4.12M | -4.23M | -6.14M |
| Cash from Operations | -43.56M | -68.92M | -92.20M | -105.18M | -120.90M |
| Capital Expenditure | -77.00K | -103.00K | -848.00K | -923.00K | -1.36M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 96.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.26M | 73.94M | 16.32M | 55.19M | 56.48M |
| Cash from Investing | 12.19M | 73.84M | 15.47M | 54.27M | 55.22M |
| Total Debt Issued | 18.00M | 18.00M | 98.00M | 98.00M | 80.00M |
| Total Debt Repaid | -29.40M | -66.06M | -73.06M | -70.05M | -45.71M |
| Issuance of Common Stock | 42.33M | 44.45M | 49.03M | 51.84M | 58.02M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.11M | -10.08M | -23.06M | -22.31M | -14.97M |
| Cash from Financing | 18.82M | -13.69M | 50.91M | 57.48M | 77.34M |
| Foreign Exchange rate Adjustments | 10.00K | -7.00K | 45.00K | 11.00K | 3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.53M | -8.78M | -25.77M | 6.58M | 11.66M |